您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

PerCP/Cyanine5.5 Anti-Human CD69 Antibody

PerCP/Cyanine5.5 Anti-Human CD69 Antibody

英诺赛图(InnoCyto)的 PerCP/Cyanine5.5 Anti-Human CD69 Antibody(克隆 FN50) 为鼠源 IgG1 单克隆抗体,靶向 CD69,PerCP/Cyanine5.5 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥2,034 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 101917 更新 2026-11-12
参考价格区间
¥2,034
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 PerCP/Cyanine5.5 Anti-Human CD69 Antibody(克隆 FN50) 为鼠源 IgG1 单克隆抗体,靶向 CD69,PerCP/Cyanine5.5 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥2,034 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

101917 | 25 tests | ¥2,034

101918 | 100 tests | ¥4,407

Product Details

Regulatory Status|RUO

Protein Concentration|Supplied at a lot-specific concentration.

Storage&Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Recommended Usage|For flow cytometric staining, it is recommended to use 5 μL of this reagent per 0.5-1.0 million cells in a 100 μL volume. Optimal reagent performance should be determined by titration for each specific application. PerCP/Cyanine5.5 has an excitation max at 482 nm and an emission max at 695 nm.

Price (Converted)|2034

See All Formats|Clone FN50

Background Information

CD69 is a type II transmembrane C-type lectin receptor that is best known as one of the earliest inducible markers of immune cell activation. It is rapidly upregulated on the surface of T cells, B cells, natural killer (NK) cells, dendritic cells, and other leukocytes following antigen receptor engagement, cytokine stimulation, or inflammatory signaling. While CD69 has long been used as a phenotypic activation marker, it is now recognized as an active regulator of immune cell localization and function.

Structurally, CD69 is expressed as a disulfide-linked homodimer. Each subunit contains a short N-terminal cytoplasmic tail, a single-pass transmembrane domain, and a C-terminal extracellular C-type lectin-like domain. Despite its classification within the C-type lectin family, CD69 does not require calcium for ligand binding. The cytoplasmic region includes signaling motifs that allow CD69 to associate with intracellular adaptor proteins and influence downstream signaling pathways, contributing to modulation of immune responses.

The most well-characterized ligand for CD69 is sphingosine-1-phosphate receptor 1 (S1PR1), a G protein–coupled receptor that controls lymphocyte egress from lymphoid organs into the circulation. CD69 physically associates with S1PR1, promoting its internalization and functional inhibition. This interaction restrains the migration of activated lymphocytes, leading to their retention within lymphoid tissues or sites of inflammation. Through this mechanism, CD69 plays a key role in the establishment and maintenance of tissue-resident memory T cells, which provide rapid, localized immune protection.

CD69 is involved in a broad range of disease processes. In infectious disease, CD69 expression marks recently activated effector cells and tissue-resident populations that contribute to protective immunity. In autoimmune and chronic inflammatory diseases, persistent CD69 expression can promote the accumulation of pathogenic lymphocytes in affected tissues, potentially exacerbating disease. Conversely, CD69 has also been shown to exert immunoregulatory effects by dampening excessive immune activation, highlighting its dual, context-dependent role. Elevated CD69 expression is commonly observed on tumor-infiltrating lymphocytes and may reflect ongoing immune activation or tissue residency within the tumor microenvironment.

From a therapeutic perspective, CD69 is primarily used as a biomarker to monitor immune activation, lymphocyte trafficking, and tissue residency in research and clinical settings. Although CD69 itself is not a major direct drug target, its functional interaction with S1PR1 has informed the development of therapies that modulate lymphocyte migration, such as sphingosine-1-phosphate receptor modulators used in autoimmune disease. Ongoing studies of CD69 biology continue to inform immunotherapeutic strategies aimed at enhancing protective immunity or limiting pathological inflammation.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 tests
CloneFN50
ApplicationFlow Cytometry
ReactivityHuman
FormatPerCP/Cyanine5.5
Target NameCD69, Very Early Activation Antigent (VEA)
IsotypeMouse IgG1
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Excitation LaserBlue Laser (488 nm)
Price (Converted)2034
目录价¥2,034

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). PerCP/Cyanine5.5 Anti-Human CD69 Antibody(101917)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/percp-cyanine5-5-anti-human-cd69-antibody.html.
TeleVM. (2026, November 12). PerCP/Cyanine5.5 Anti-Human CD69 Antibody(101917). 产品目录. https://www.suprotek.cn/products/item/percp-cyanine5-5-anti-human-cd69-antibody.html
@misc{biocsp_item_percp_cyanine5_5_anti_human_cd69_antibody,
  title        = {PerCP/Cyanine5.5 Anti-Human CD69 Antibody(101917)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/percp-cyanine5-5-anti-human-cd69-antibody.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

PerCP/Cyanine5.5 Anti-Human CD69 Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。